Clinical Trial Update: Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a randomized, double-blind, placebo-controlled, dose-ranging study evaluating SSR149744C (50, 100, 200, or 300 mg once dai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Amiodarone (amiodarone)
• SSR149744c (SSR149744c)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 2, Phase 3 | Status: COMPLETED